Articles | Open Access | DOI: https://doi.org/10.37547/ijmscr/Volume03Issue10-04

MODERN TREATMENT AND CORRECTION OF THE CONSEQUENCES OF LOCALIZED SCLERODERMA

I.O. Nigmatov , Researcher, Tashkent Medical Academy, Uzbekistan

Abstract

Localized scleroderma (LS) is an inflammatory sclerosing disease of the skin and subcutaneous tissues associated with their atrophy. Depending on the subtype, severity of the disease and localization of the lesion, involvement in the pathological process of adipose tissue, muscles, joints and bones, but not internal organs, is noted. The annual primary incidence of drugs in childhood is 3.4 cases per 1,000,000 child population; in females, the disease occurs 2.6–6 times more often. The wide range of clinical manifestations of the disease has led to the emergence of a large number of different classifications, which take into account the severity, prevalence and depth of the fibrosis process, as a result of which five main clinical forms of LS are distinguished: limited, generalized, linear, deep and mixed. The forms of drugs are not mutually exclusive, since the same patient may experience different manifestations of the disease. One of the most common forms of LS in childhood is the linear form, which is observed in approximately 40–70% of children.

Keywords

localized scleroderma, lipofilling, maxillofacial area

References

ELFadl D., Garimella V., Mahapatra TK et al. Lipomodeling of the breast: a review. Breast. 2010;19(3):202-9.

Leopardi D. et al. Systematic review of autologous fat transfer for cosmetic and reconstructive breast augmentation. Adelaide, South Australia: ASERNIP-S, 2010.

Illouz YG, Sterodimas A. Autologous fat transplantation to the breast: a personal technique with 25 years of experience. Aesthetic Plast Surg. 2009;33(5): 706-15.

Gutowski K.A.; ASPS Fat Graft Task Force. Current applications and safety of autologous fat grafts: a report of the ASPS fat graft task force. Plast Reconstr Surg. 2009;124(1):272-80.

Schultz I., Lindegren A., Wickman M. Improved shape and consistency after lipofilling of the breast: patients' evaluation of the outcome. J Plast Hand Surg. 2012;46(2):85-90.

Coleman SR Facial augmentation with structural fat grafting. Clin Plast Surg. 2006;33(4):567-77.

Ozsoy Z., Kul Z., Bilir A. The role of cannula diameter in improved adipocyte viability: a quantitative analysis. Aesthet Surg J 2006;26(3):287-9.

Erdim M., Tezel E., Numanoglu A., Sav A. The effects of the size of liposuction cannula on adipocyte survival and the optimum temperature for fat graft storage: an experimental study. J Plast Reconstr Aesthet Surg.

2009;62(9):1210-4.

Leong DT, Hutmacher DW, Chew FT, Lim TC Viability and adipogenic potential of human adipose tissue processed cell population obtained from pump-assisted and syringe-assisted liposuction. J Dermatol Sci. 2005;37(3):169-76.

Smith P., Adams WP Jr., Lipschitz AH et al. Autologous human fat grafting: effect of harvesting and preparation techniques on adipocyte graft survival. Plast Reconstr Surg. 2006;117(6):1836-44.

Vona-Davis L., Rose DP Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer. 2007;14(2):189-206.

Article Statistics

Copyright License

Download Citations

How to Cite

I.O. Nigmatov. (2023). MODERN TREATMENT AND CORRECTION OF THE CONSEQUENCES OF LOCALIZED SCLERODERMA. International Journal of Medical Sciences And Clinical Research, 3(10), 18–23. https://doi.org/10.37547/ijmscr/Volume03Issue10-04